Guerrero Ramiro
SEC Form 4 insider trading activity
Guerrero Ramiro has filed 4 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Sep 14, 2026.
On the most recent filing, Guerrero Ramiro is listed as Director at MAIA Biotechnology, Inc. Inside the rolling window, Guerrero Ramiro reported 6 open-market purchases totaling $252K in MAIA and no open-market sales. The largest disclosed transaction in the window is a purchase of 78,239 MAIA shares on Aug 27, 2026, worth $109K.
Companies traded
Other insiders at MAIA
Insider Buying
$252K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Guerrero Ramiro made?
Guerrero Ramiro has filed 4 SEC Form 4 filings (6 transaction rows) across 1 company since 2026.
Which companies does Guerrero Ramiro trade?
Guerrero Ramiro has filed SEC Form 4 disclosures for 1 company, including MAIA.
When was Guerrero Ramiro's most recent SEC Form 4 filing?
Guerrero Ramiro's most recent SEC Form 4 filing on Tracefour is dated Sep 14, 2026.
What is Guerrero Ramiro's total buy and sell value in the current window?
Inside the rolling retention window, Guerrero Ramiro bought $252K and sold $0 based on SEC Form 4 filings.
What was Guerrero Ramiro's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 78,239 MAIA shares on 2026-08-27, worth $109K, per SEC Form 4 filings.